Journal of Pain and Symptom Management
Volume 38, Issue 3 , Pages 365-371 , September 2009

Off-Label Prescriptions in Italian Hospices: A National Survey

  • Franco Toscani, MD

      Affiliations

    • Lino Maestroni Foundation Palliative Medicine Research Institute, Cremona, Italy
    • Corresponding Author InformationAddress correspondence to: Franco Toscani, MD, Lino Maestroni Foundation Palliative Medicine Research Institute, via Palestro 1, 26100 Cremona, Italy.
  • ,
  • Paola Di Giulio, RN, MSC

      Affiliations

    • Department of Public Health and Microbiology, University of Torino, Torino, Italy
  • ,
  • Rita Campi, ScD

      Affiliations

    • Laboratory of Mother and Child Health, Mario Negri Institute, Milan, Italy
  • ,
  • Ivanoe Pellerin, MD

      Affiliations

    • Palliative Care Unit, Hospital of Legnano, Legnano, Italy
  • ,
  • Anna De Luca, MD

      Affiliations

    • Palliative Care Unit, Ospedale San Giovanni Battista, Torino, Italy
  • ,
  • Giuseppe Casale, MD

      Affiliations

    • Antea Foundation, Rome, Italy
  • ,
  • End of Life Observatory Research Group

,Accepted 10 December 2008.

References 

  1. Atkinson CV, Kirkham SR. Unlicensed uses for medication in a palliative care unit. Palliat Med. 1999;13:145–152
  2. Davis MP. Palliative medicine: old dogs and new tricks. Cleve Clin J Med. 2000;67:557–559
  3. Radley DC, Finkelstein SN, Stafford RS. Off-label prescribing among office-based physicians. Arch Intern Med. 2006;166:1021–1026
  4. Trifirò G, Spina E, Brignoli O, et al. Antipsychotic prescribing patterns among Italian general practitioners: a population-based study during the years 1999-2002. Eur J Clin Pharmacol. 2005;61:47–53
  5. Kogut SJ, Yam F, Dufresne R. Prescribing of antipsychotic medication in a medicaid population: use of polytherapy and off-label dosages. J Manag Care Pharm. 2005;11:17–24
  6. Haw C, Stubbs J. A survey of the off-label use of mood stabilizers in a large psychiatric hospital. J Psychopharmacol. 2005;19:402–407
  7. Pavis H, Wilcock A. Prescribing of drugs for use outside their license in palliative care: survey of specialists in the United Kingdom. BMJ. 2001;323:484–485
  8. Weschules DJ, Maxwell T, Reifsnyder J, Knowlton CH. Are newer, more expensive pharmacotherapy options associated with superior symptom control compared to less costly agents used in a collaborative practice setting?. Am J Hosp Palliat Care. 2006;23:135–149
  9. Todd J, Davies A. Use of unlicensed medication in palliative medicine. Palliat Med. 1999;13:446
  10. Fonzo-Christe C, Vukasovic C, Wasilewski-Rasca AF, Bonnabry P. Subcutaneous administration of drugs in the elderly: survey of practice and systematic literature review. Palliat Med. 2005;19:208–219
  11. O'Doherty CA, Hall EJ, Schofield L, Zeppetella G. Drugs and syringe drivers: a survey of adult specialist palliative care practice in the United Kingdom and Eire. Palliat Med. 2001;15:149–154
  12. Zachrisson U, Fürst CJ. Drug infusors in palliative medicine: a Swedish inquiry. J Pain Symptom Manage. 1998;15:299–304
  13. Cherny NJ, Chang V, Frager G, et al. Opioid pharmacotherapy in the management of cancer pain: a survey of strategies used by pain physicians for the selection of analgesic drugs and routes of administration. Cancer. 1995;76:1283–1293
  14. Art. 3, comma 2, Law 8 April 1998, n. 94. Gazzetta Ufficiale 1998; 86 (April 14, 1998). Available at: http://www.camera.it/parlam/leggi/980941.htm. Accessed June 24, 2009.
  15. Società Italiana di cure palliative. Hospice in Italia. Prima rilevazione ufficiale 2006. Available at: http://www.sicp.it/hospice_menu.asp. Accessed June 24, 2009.
  16. OEMF . REFI—Repertorio Farmacologico Italiano (CD-ROM). 13th ed.. OEMF-Masson, Milan, Italy; 2003;
  17. Agenzia Italiana del Farmaco . PFN 2005. Rome: Istituto Poligrafico dello Stato; 2005;
  18. Twycross R, Wilcock A, Charlesworth S, Dickman A. Palliative care formulary. 2nd ed.. Abingdon: Radcliffe Medical Press; 2002;
  19. In:  Metha DK editors. British national formulary. 48th ed.. London: Pharmaceutical Press; 2004;
  20. Ferner RE. Prescribing licensed medicines for unlicensed indications. Prescriber's J. 1996;36:73–79
  21. Back IN, Jenkins K, Blower A, Beckhelling J. A study comparing hyoscine hydrobromide and glycopyrrolate in the treatment of death rattle. Palliat Med. 2001;15:329–336
  22. Janssens JP, de Muralt B, Titelion VJ. Management of dyspnea in severe chronic obstructive pulmonary disease. J Pain Symptom Manage. 2000;19:378–392
  23. Jennings AL, Davies AN, Higgins JP, Gibbs JS, Broadley KE. A systematic review of the use of opioids in the management of dyspnoea. Thorax. 2002;57:939–944
  24. Vadell C, Seguí MA, Giménez-Arnau JM, et al. Anticachectic efficacy of megestrol acetate at different doses and versus placebo in patients with neoplastic cachexia. Am J Clin Oncol. 1998;21:347–351
  25. Myers KG, Trotman IF. Use of ketorolac by continuous subcutaneous infusion for the control of cancer-related pain. Postgrad Med J. 1994;70:359–362
  26. Hughes A, Wilcock A, Corcoran R. Ketorolac: continuous subcutaneous infusion for cancer pain. J Pain Symptom Manage. 1997;13:315–316
  27. Morichon E. Guide to the administration of subcutaneous drugs. (French) Bulletin. d'Information du médicament et de pharmacovigilance. 2006;128:1–6
  28. Jonhson I, Patterson S. Drugs used in combination in the syringe driver. Palliat Med. 1992;6:125–130
  29. O'Neill WM. Subcutaneous infusion—a medical last rite. Palliat Med. 1994;8:91–93
  30. Wilcock A, Jacob JK, Charlesworth S, et al. Drugs given by a syringe driver: a prospective multicentre survey of palliative care services in the UK. Palliat Med. 2006;20:661–664
  31. Drummond SH, Peterson GM, Galloway JG, Keefe PA. National survey of drug use in palliative care. Palliat Med. 1996;10:119–124
  32. Good PD, Schneider JJ, Ravenscroft PJ. The compatibility and stability of midazolam and dexamethasone in infusion solutions. J Pain Symptom Manage. 2004;27:471–475

 This study was supported by a grant from the Luogo di Vitae e di Incontro Foundation of Milan.

 A complete list of investigators is reported in the Appendix.

PII: S0885-3924(09)00532-6

doi: 10.1016/j.jpainsymman.2008.11.014

Journal of Pain and Symptom Management
Volume 38, Issue 3 , Pages 365-371 , September 2009